 | ENDOCRINE HYPERTENSION
Copyright © 2002 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 970:61-76 (2002)
© 2002 New York Academy of Sciences
Primary Aldosteronism
Management Issues
WILLIAM F. YOUNG, Jr.
Division of Endocrinology and Metabolism, and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Address for correspondence: William F. Young, Jr., M.D., Mayo Clinic, W18 Mayo Building, 200 First Street S.W., Rochester, MN 55905. Voice: 507-284-2191; fax: 507-284-5745.
Young.William{at}Mayo.edu
Ann. N.Y. Acad. Sci. 970: 61-76 (2002).
Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of hypertension. However, improved screening methods show that primary aldosteronism is a common form of secondary hypertension. Diagnosis of this disorder results in improved or cured hypertension or targeted pharmacotherapy. Patients with hypertension and hypokalemia and most patients with treatment-resistant hypertension should undergo screening for primary aldosteronism. A random and ambulatory ratio of plasma aldosterone concentration (PAC) to plasma renin activity (PRA) that is elevated and a PAC higher than a set cutoff is a positive screen for primary aldosteronism. An increased PAC/PRA ratio alone is not diagnostic of primary aldosteronism; primary aldosteronism must be confirmed by demonstrating inappropriate aldosterone secretion with either the intravenous saline suppression test or measurement of 24-hr urinary aldosterone while the patient is on a high-sodium diet. The two major subtypes of primary aldosteronism are unilateral aldosterone-producing adenoma (APA) and bilateral idiopathic hyperplasia (IHA). Patients with APA are usually treated with unilateral adrenalectomy, and patients with IHA are treated medically. The subtype evaluation may require one or more tests, the first of which is imaging the adrenals with computerized tomography (CT). When a solitary unilateral macroadenoma (> 1 cm) and normal contralateral adrenal morphologic pattern are found on CT in a young patient with primary aldosteronism, unilateral laparoscopic adrenalectomy is a reasonable therapeutic option. However, in many cases, CT imaging may reveal normal-appearing adrenals or ambiguous findings. Adrenal venous sampling helps to resolve these clinical dilemmas.
Key Words: hyperaldosteronism • hypertension • adrenal • hypokalemia
This article has been cited by other articles:
|
|
|
|
 
P. Mulatero, C. Bertello, D. Rossato, G. Mengozzi, A. Milan, C. Garrone, G. Giraudo, G. Passarino, D. Garabello, A. Verhovez, et al.
Roles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes
J. Clin. Endocrinol. Metab.,
April 1, 2008;
93(4):
1366 - 1371.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Umpierrez, P. Cantey, D. Smiley, A. Palacio, D. Temponi, K. Luster, and A. Chapman
Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
Diabetes Care,
July 1, 2007;
30(7):
1699 - 1703.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Schirpenbach, L. Seiler, C. Maser-Gluth, F. Rudiger, C. Nickel, F. Beuschlein, and M. Reincke
Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
Eur. J. Endocrinol.,
June 1, 2006;
154(6):
865 - 873.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-C. Tiu, C.-H. Choi, C.-C. Shek, Y.-W. Ng, F. K. W. Chan, C.-M. Ng, and A. P. S. Kong
The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
72 - 78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. H. Perschel, R. Schemer, L. Seiler, M. Reincke, J. Deinum, C. Maser-Gluth, D. Mechelhoff, R. Tauber, and S. Diederich
Rapid Screening Test for Primary Hyperaldosteronism: Ratio of Plasma Aldosterone to Renin Concentration Determined by Fully Automated Chemiluminescence Immunoassays
Clin. Chem.,
September 1, 2004;
50(9):
1650 - 1655.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Mulatero, M. Stowasser, K.-C. Loh, C. E. Fardella, R. D. Gordon, L. Mosso, C. E. Gomez-Sanchez, F. Veglio, and W. F. Young Jr.
Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1045 - 1050.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. F. Young Jr.
Minireview: Primary Aldosteronism--Changing Concepts in Diagnosis and Treatment
Endocrinology,
June 1, 2003;
144(6):
2208 - 2213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
